Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation
The main protease (3-chymotrypsin-like protease, 3CLpro) of SARS-CoV-2 has become a focus of anti-coronavirus research. Despite efforts, drug development targeting 3CLpro has been hampered by limitations in the currently available activity assays. Additionally, the emergence of 3CLpro mutations in c...
Saved in:
| Main Authors: | Zhu-Chun Bei, Huanhuan Yu, Hong Wang, Qingyun Li, Baogang Wang, Dongna Zhang, Likun Xu, Liangliang Zhao, Shuwei Dong, Yabin Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2211688 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
by: Qian Wang, et al.
Published: (2024-10-01) -
Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials
by: Nicole Jean Lee, et al.
Published: (2025-08-01) -
Drug repurposing targeting COVID-19 3CL protease using molecular docking and machine learning regression approaches
by: Imra Aqeel, et al.
Published: (2025-05-01) -
Enhancing Flavor in Dried Mackerel Floss (<i>Scomberomorus niphonius</i>) via Protease: Formation Mechanism of Characteristic Flavor Revealed by Integrated Multi-Omics Analysis
by: Diqian Yang, et al.
Published: (2025-05-01) -
Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases
by: Douglas S. Watson, et al.
Published: (2011-08-01)